posted on: August 06, 2008 | about stocks: BMRN Executives Eugenia Shen - Senior Manager, IR Jean-Jacques Bienaimé - CEO Jeffrey H. Cooper - Sr. VP, CFO Stephen Aselage - Sr. VP, Global Commercial Development Emil D. Kakkis, M.D., Ph.D. - Sr. VP, Chief Medical Officer Analysts Christopher Raymond - Robert W. Baird & Company Joseph Schwartz - Leerink Swann Philip Nadeau - Cowen & Co. Thomas McGahren - Merrill Lynch Liana Moussatos - Pacific Growth Equities Carol Werther - Summer Street Research Vernon Bernardino - Rodman & Renshaw Andrew Vaino - Roth Capital Lucy Lou - Citigroup Operator Good day ladies and gentlemen and welcome to the Second Quarter 2008 BioMarin Pharmaceutical Inc. Earnings Conference Call. My name is Amy and I'll be your coordinator for today. At this time, all participants are in listen-only mode. We will...
[read full story]